- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
SurvBridge transfers survival representations across clinical cohorts with partially overlapping feature schemas. It encodes feature identity with a frozen BioLORD encoder, adds learned missingness embeddings, pretrains with multi-source contrastive learning on MIMIC-IV, eICU, HiRID and an unlabeled Kaggle cohort using a survival-weighted negative term, then fine-tunes a Cox head. It is evaluated on two private cohorts (URRAH, IHD) and three public ones (SUPPORT2, SMARTO, FLCHAIN) using Ctd, plus low-resource and convergence analyses.
Critical strengths
The paper is well engineered and the evaluation is broad by this subfield's standards: the baseline suite includes tabular foundation models, the low-resource curve and convergence-time table are informative, and the paired-seed analyses are more careful than usual. Ethics documentation for the PhysioNet data is explicit.
Critical weaknesses
- The headline gains sit within seed noise: on URRAH, SurvBridge (Scratch) scores 0.855 [0.849, 0.861] against SurvTRACE at 0.851 [0.843, 0.858], a difference of +0.004, and on IHD, VPCL scores 0.803 against Scratch at 0.800.
- The missingness contribution is +0.003 to +0.006 with seed confidence intervals of +/-0.004 to 0.016; all tests are seed-level (n = 5), and no patient-level confidence intervals or tests are reported, so the repeated-seed design cannot separate method effects from run variance.
- The abstract's "strong survival discrimination" does not hold on SUPPORT2, where Scratch (0.755) is below CoxPH (0.769) and TabPFN-MTLR (0.774).
- The URRAH missingness rates differ between Fig. 4 and Fig. 7 for the same features (AF 89.2% vs 86.7%, BUN 53.0% vs 47.7%, Heart Rate 13.7% vs 17.2%), and for Alcohol the rank order flips (20.0% vs 27.9%).
- In Table 5, the "BERT" row equals Table 1's SurvBridge (Scratch) exactly and "BioLORD" equals SurvBridge (SurvVPCL), so the encoder ablation is confounded with the pretraining objective.
- The variance reported in Fig. 8 does not match its own axes (text 55.7% for PC1+PC2 versus 36.2% + 22.2% = 58.4% plotted), and Fig. 10/11 time axes for URRAH and IHD imply a 23x difference while the reported medians differ by only 1.8x, suggesting mixed units.
- The baseline comparison is unequal on the missingness dimension: baselines use median imputation while SurvBridge uses learned missingness embeddings, and URRAH is 39.6% missing, so the comparison partially measures imputation strategy rather than transfer.
- TransTab-Cox appears in the results but is absent from the hyperparameter search spaces in Table 3.
Questions for authors
- Why do URRAH missingness rates differ between Fig. 4 and Fig. 7, and which is correct?
- Does Table 5 hold pretraining fixed when swapping encoders, or are those rows mislabeled?
- Can you report patient-level confidence intervals and paired tests rather than seed-level ones?
- What are the units in Fig. 10/11, and is the URRAH axis correct?
- Are MIMIC-IV-Surv and eICU-Surv patients disjoint from the pretraining pools?
Thank you very much for your feedback. We include below answers to your questions. We have uploaded a new version of the paper (and a pdf with changes in blue as part of the supplementary material).
Q1: Figure 4 reports the missingness rate on the first seed’s training split, while Figure 7 contains the entire dataset.
Q2: Unfortunately there was a mixup between results of the final models and a previous version. We have replaced the second row in table 5 with the correct model version. Now, only the first row in table 5 is equal to the SurvBridge (Scratch) row in table 1, as should have been from the beginning. Thank you for noticing the issue.
Q3: Unfortunately due to time constraints we were not able to recompute patient level CIs. However, seed level intervals also incorporate some patient-level variability, since for different seeds the test datasets change.
Q4: The figures used months for the URRAH dataset and days for IHD. We changed the figure to always report days.
Q5: Yes, the MIMIC-IV and eICU patients used for downstream survival prediction are not used for pretraining.
General comments: We have rephrased the text in general to clarify better that the superiority of our method is not for all datasets, and that SurvVPCL is not better than VPCL. We underline that SurvVPCL was not the only novelty of our model: SurvBridge also incorporates missing value embeddings and combines TransTab-style encoding with the Cox survival prediction head, demonstrating overall superiority compared to the state of the art in almost all datasets studied, even without pre-training (scratch). Indeed, missingness representation is an important improvement over the state of the art. Regarding figure 8, there was an error reporting the explained variance, we have fixed it. Adjusted the number to 58.4% Regarding TransTab-Cox, we have added the details to Table 3, we mistakenly excluded it.